vs
Side-by-side financial comparison of Bitcoin Depot Inc. (BTM) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Bitcoin Depot Inc. is the larger business by last-quarter revenue ($162.5M vs $151.7M, roughly 1.1× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 3.4%, a 4.4% gap on every dollar of revenue. On growth, Bitcoin Depot Inc. posted the faster year-over-year revenue change (20.1% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $2.5M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -4.9%).
Bitcoin Depot Inc. is one of the largest cryptocurrency ATM operators across North America. It provides retail consumers with accessible in-person kiosks to buy and sell Bitcoin and other leading digital assets, alongside online crypto purchase services via bank transfer. Its self-service kiosks are located in high-traffic retail spaces including grocery stores, gas stations and convenience stores.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
BTM vs NUTX — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $162.5M | $151.7M |
| Net Profit | $5.5M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | 7.3% | 20.4% |
| Net Margin | 3.4% | 7.8% |
| Revenue YoY | 20.1% | -41.1% |
| Net Profit YoY | 690.4% | -80.8% |
| EPS (diluted) | $0.08 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $151.7M | ||
| Q3 25 | $162.5M | $267.8M | ||
| Q2 25 | $172.1M | $244.0M | ||
| Q1 25 | $164.2M | $211.8M | ||
| Q4 24 | — | $257.6M | ||
| Q3 24 | $135.3M | $78.8M | ||
| Q2 24 | $163.1M | $76.1M | ||
| Q1 24 | $138.5M | $67.5M |
| Q4 25 | — | $11.8M | ||
| Q3 25 | $5.5M | $55.4M | ||
| Q2 25 | $6.1M | $-17.7M | ||
| Q1 25 | $4.2M | $21.2M | ||
| Q4 24 | — | $61.6M | ||
| Q3 24 | $-939.0K | $-8.8M | ||
| Q2 24 | $-2.6M | $-364.0K | ||
| Q1 24 | $-1.5M | $-364.0K |
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% | ||
| Q1 24 | — | 15.1% |
| Q4 25 | — | 20.4% | ||
| Q3 25 | 7.3% | 48.7% | ||
| Q2 25 | 9.2% | 13.8% | ||
| Q1 25 | 10.8% | 38.1% | ||
| Q4 24 | — | 44.4% | ||
| Q3 24 | 4.1% | 12.3% | ||
| Q2 24 | 4.7% | 7.0% | ||
| Q1 24 | 0.5% | 2.1% |
| Q4 25 | — | 7.8% | ||
| Q3 25 | 3.4% | 20.7% | ||
| Q2 25 | 3.5% | -7.3% | ||
| Q1 25 | 2.6% | 10.0% | ||
| Q4 24 | — | 23.9% | ||
| Q3 24 | -0.7% | -11.2% | ||
| Q2 24 | -1.6% | -0.5% | ||
| Q1 24 | -1.1% | -0.5% |
| Q4 25 | — | $2.34 | ||
| Q3 25 | $0.08 | $7.76 | ||
| Q2 25 | $0.16 | $-2.95 | ||
| Q1 25 | $0.20 | $3.33 | ||
| Q4 24 | — | $11.56 | ||
| Q3 24 | $-0.05 | $-1.72 | ||
| Q2 24 | $-0.13 | $-0.07 | ||
| Q1 24 | $-0.25 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $59.3M | $185.6M |
| Total DebtLower is stronger | $67.5M | — |
| Stockholders' EquityBook value | $21.0M | $329.4M |
| Total Assets | $125.3M | $918.5M |
| Debt / EquityLower = less leverage | 3.21× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $185.6M | ||
| Q3 25 | $59.3M | $166.0M | ||
| Q2 25 | $48.0M | $96.7M | ||
| Q1 25 | $35.0M | $84.7M | ||
| Q4 24 | — | $40.6M | ||
| Q3 24 | $32.2M | $46.9M | ||
| Q2 24 | $43.9M | $40.8M | ||
| Q1 24 | $42.2M | $30.0M |
| Q4 25 | — | — | ||
| Q3 25 | $67.5M | — | ||
| Q2 25 | $66.5M | — | ||
| Q1 25 | $56.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $44.5M | — | ||
| Q2 24 | $41.2M | — | ||
| Q1 24 | $37.6M | — |
| Q4 25 | — | $329.4M | ||
| Q3 25 | $21.0M | $317.2M | ||
| Q2 25 | $4.7M | $235.3M | ||
| Q1 25 | $-4.6M | $176.9M | ||
| Q4 24 | — | $132.4M | ||
| Q3 24 | $-7.9M | $60.4M | ||
| Q2 24 | $4.4M | $62.7M | ||
| Q1 24 | $5.0M | $63.0M |
| Q4 25 | — | $918.5M | ||
| Q3 25 | $125.3M | $964.5M | ||
| Q2 25 | $109.1M | $841.0M | ||
| Q1 25 | $89.7M | $761.9M | ||
| Q4 24 | — | $655.3M | ||
| Q3 24 | $87.4M | $438.5M | ||
| Q2 24 | $97.5M | $422.4M | ||
| Q1 24 | $90.1M | $404.3M |
| Q4 25 | — | — | ||
| Q3 25 | 3.21× | — | ||
| Q2 25 | 14.18× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 9.27× | — | ||
| Q1 24 | 7.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.6M | $70.4M |
| Free Cash FlowOCF − Capex | $2.5M | $69.0M |
| FCF MarginFCF / Revenue | 1.6% | 45.5% |
| Capex IntensityCapex / Revenue | 2.5% | 0.9% |
| Cash ConversionOCF / Net Profit | 1.20× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $27.1M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $70.4M | ||
| Q3 25 | $6.6M | $99.5M | ||
| Q2 25 | $10.2M | $27.3M | ||
| Q1 25 | $16.3M | $51.0M | ||
| Q4 24 | — | $54.0K | ||
| Q3 24 | $5.8M | $6.8M | ||
| Q2 24 | $10.1M | $13.3M | ||
| Q1 24 | $1.3M | $3.1M |
| Q4 25 | — | $69.0M | ||
| Q3 25 | $2.5M | $99.2M | ||
| Q2 25 | $9.8M | $26.5M | ||
| Q1 25 | $15.9M | $50.9M | ||
| Q4 24 | — | $-341.0K | ||
| Q3 24 | $-1.0M | $6.2M | ||
| Q2 24 | $7.6M | $12.7M | ||
| Q1 24 | $789.0K | $2.3M |
| Q4 25 | — | 45.5% | ||
| Q3 25 | 1.6% | 37.0% | ||
| Q2 25 | 5.7% | 10.9% | ||
| Q1 25 | 9.7% | 24.0% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | -0.8% | 7.8% | ||
| Q2 24 | 4.7% | 16.7% | ||
| Q1 24 | 0.6% | 3.4% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 2.5% | 0.1% | ||
| Q2 25 | 0.2% | 0.3% | ||
| Q1 25 | 0.2% | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 5.0% | 0.8% | ||
| Q2 24 | 1.5% | 0.7% | ||
| Q1 24 | 0.4% | 1.1% |
| Q4 25 | — | 5.95× | ||
| Q3 25 | 1.20× | 1.80× | ||
| Q2 25 | 1.67× | — | ||
| Q1 25 | 3.88× | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BTM
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
